Tamara Tompkins Net Worth

The estimated Net Worth of Tamara Tompkins is at least $1.75 million dollars as of 11 July 2011. Ms. Tompkins owns over 12,650 units of Unity Biotechnology Inc stock worth over $67,200 and over the last 14 years she sold UBX stock worth over $1,683,776. In addition, she makes $0 as General Counsel and Corporate Secretary at Unity Biotechnology Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Tompkins UBX stock SEC Form 4 insiders trading

Tamara has made over 4 trades of the Unity Biotechnology Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently she sold 12,650 units of UBX stock worth $348,255 on 11 July 2011.

The largest trade she's ever made was selling 17,175 units of Unity Biotechnology Inc stock on 9 June 2011 worth over $492,407. On average, Tamara trades about 4,769 units every 8 days since 2010. As of 11 July 2011 she still owns at least 48,000 units of Unity Biotechnology Inc stock.

You can see the complete history of Ms. Tompkins stock trades at the bottom of the page.

Tamara Tompkins biography

Tamara L. Tompkins J.D. serves as General Counsel and Corporate Secretary of the Company. Prior to that, Ms. Tompkins served as an Operating Partner, General Counsel, and Chief Administrative Officer of Khosla Ventures, a venture capital firm, from January 2013 to December 2016. From February 2005 to May 2012, Ms. Tompkins served as General Counsel of Amyris, Inc., a public bio-renewables company. She began her career in private practice, first with Shearman & Sterling, then Brobeck, Phleger & Harrison, and finally as Of Counsel at Morgan Lewis. Ms. Tompkins received a B.A. in History from Middlebury College and a J.D. from Georgetown University.

How old is Tamara Tompkins?

Tamara Tompkins is 55, she's been the General Counsel and Corporate Secretary of Unity Biotechnology Inc since 2017. There are 9 older and 12 younger executives at Unity Biotechnology Inc. The oldest executive at Unity Biotechnology Inc is David Lacey, 67, who is the Independent Director.

What's Tamara Tompkins's mailing address?

Tamara's mailing address filed with the SEC is C/O UNITY BIOTECHNOLOGY, INC., 285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Unity Biotechnology Inc

Over the last 7 years, insiders at Unity Biotechnology Inc have traded over $9,012,473 worth of Unity Biotechnology Inc stock and bought 3,200 units worth $28,480 . The most active insiders traders include Kristina Burow, Robert Nelsen et Nathaniel E David. On average, Unity Biotechnology Inc executives and independent directors trade stock every 54 days with the average trade being worth of $65,316. The most recent stock trade was executed by Alexander Hieu Nguyen on 2 August 2024, trading 154 units of UBX stock currently worth $236.

What does Unity Biotechnology Inc do?

unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.

Complete history of Ms. Tompkins stock trades at Amyris Inc et Unity Biotechnology Inc

Unity Biotechnology Inc executives and stock owners

Unity Biotechnology Inc executives and other stock owners filed with the SEC include:

• Keith Leonard,
  Chairman of the Board
• Margo Roberts,
  Independent Director
• Nathaniel David,
  President, Co-Founder, Director
• Dr. Anirvan Ghosh,
  CEO & Director
• Dr. Jamie Dananberg M.D.,
  Chief Medical Officer
• Dr. Jamie Dananberg,
  Chief Medical Officer
• Lynne Marie Sullivan,
  CFO & Head of Corp. Devel.
• Paul Berns,
  Independent Director
• Graham Cooper,
  Independent Director
• David Lacey,
  Independent Director
• Kristina Burow,
  Independent Director
• Camille Samuels,
  Independent Director
• Robert Nelsen,
  Director
• Dr. Nathaniel E. David A.B., Ph.D.,
  Co-Founder & Exec. Director
• Luis Visoso,
  Director
• Mary Campbell,
  Director
• Jamie Dananberg,
  Chief Medical Officer
• Tamara Tompkins,
  General Counsel and Corporate Secretary
• Dan Marquess,
  Chief Scientific Officer
• Lynne Sullivan,
  Chief Financial Officer, Chief Accounting Officer
• Anirvan Ghosh,
  Chief Executive Officer, Director
• Dr. Nathaniel E. David,
  Co-Founder & Exec. Director
• Susan Lundeen Smuck,
  Chief HR Officer
• Dr. Przemyslaw Sapieha Ph.D.,
  Chief Scientific Advisor
• Alexander Azoy,
  VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer
• Nathan Guz Ph.D.,
  VP of Operations
• Daohong Zhou M.D.,
  Founder
• Dr. Judith Campisi,
  Founder
• Dr. Jan M. van Deursen,
  Founder
• Alexander Azoy,
  See Remarks
• Alexander Hieu Nguyen,
  Chief Legal Officer
• Ii Robert C. Goeltz,
  Chief Financial Officer
• Venture Partners Vii, Llcar...,
  
• Michael P. Samar,
  
• Gilmore Neil O'neill,